Toru Nakanishi
Papers
1
Total Citations
5
H-Index
1
About
Toru Nakanishi is a leading figure in gynecologic oncology, with a focused expertise in the surgical management of uterine cervical cancer. His primary research area is the development and validation of less invasive surgical techniques for early-stage disease, aiming to reduce patient morbidity without compromising oncologic safety. Nakanishi’s major contribution is his leadership in the Japan Clinical Oncology Group study, JCOG1101, a landmark confirmatory trial that rigorously evaluated modified radical hysterectomy for patients with FIGO stage IB1 cervical cancer with tumors ≤2 cm. This work, published in 2023, provides critical evidence supporting a shift away from the highly invasive standard Piver class III hysterectomy. While the paper is recent with 5 citations, its impact is foundational, representing a paradigm-shifting effort to establish a new standard of care. Nakanishi’s work is central to the ongoing global conversation about de-escalation of surgical radicality, balancing cure with quality of life. His research directly informs clinical guidelines and offers a promising, evidence-based path toward safer, more patient-centered treatment for early cervical cancer.
Research Focus
Key Achievements
Top Papers
- 1